XML 46 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 25,643us-gaap_CashAndCashEquivalentsAtCarryingValue $ 28,751us-gaap_CashAndCashEquivalentsAtCarryingValue
Restricted cash 543us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue 154us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue
Short-term bank deposits 47,000us-gaap_OtherShortTermInvestments 18,015us-gaap_OtherShortTermInvestments
Investment in Evogene 1,054us-gaap_AvailableForSaleSecuritiesCurrent 4,565us-gaap_AvailableForSaleSecuritiesCurrent
Other accounts receivable and prepaid expenses 858us-gaap_PrepaidExpenseAndOtherAssetsCurrent 1,731us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 75,098us-gaap_AssetsCurrent 53,216us-gaap_AssetsCurrent
NON-CURRENT ASSETS:    
Long-term bank deposits 35,026us-gaap_LongTermInvestments   
Long-term prepaid expenses 108us-gaap_PrepaidExpenseNoncurrent 158us-gaap_PrepaidExpenseNoncurrent
Severance pay fund 2,024cgen_SeverancePayFundNoncurrent 2,129cgen_SeverancePayFundNoncurrent
Property and equipment, net 2,730us-gaap_PropertyPlantAndEquipmentNet 1,208us-gaap_PropertyPlantAndEquipmentNet
Total non-current assets 39,888us-gaap_AssetsNoncurrent 3,495us-gaap_AssetsNoncurrent
Total assets 114,986us-gaap_Assets 56,711us-gaap_Assets
CURRENT LIABILITIES:    
Trade payables 1,493us-gaap_AccountsPayableCurrent 693us-gaap_AccountsPayableCurrent
Deferred revenue 1,789us-gaap_DeferredRevenueCurrent 5,318us-gaap_DeferredRevenueCurrent
Research and development funding arrangement 421cgen_ResearchAndDevelopmentFundingArrangementCurrent   
Other accounts payable and accrued expenses 2,886us-gaap_OtherAccountsPayableAndAccruedLiabilities 1,728us-gaap_OtherAccountsPayableAndAccruedLiabilities
Total current liabilities 6,589us-gaap_LiabilitiesCurrent 7,739us-gaap_LiabilitiesCurrent
NON-CURRENT LIABILITIES:    
Research and development funding arrangement    13,189cgen_ResearchAndDevelopmentFundingArrangementNoncurrent
Deferred revenue    1,454us-gaap_DeferredRevenueNoncurrent
Accrued severance pay 2,281us-gaap_PostemploymentBenefitsLiabilityNoncurrent 2,441us-gaap_PostemploymentBenefitsLiabilityNoncurrent
Total non-current liabilities 2,281us-gaap_LiabilitiesNoncurrent 17,084us-gaap_LiabilitiesNoncurrent
COMMITMENTS AND CONTINGENT LIABILITIES      
SHAREHOLDERS' EQUITY:    
Share capital: Ordinary shares of NIS 0.01 par value: 100,000,000 shares authorized at December 31, 2014 and 2013; 50,254,492 and 41,002,113 shares issued and outstanding at December 31, 2014 and 2013, respectively 137us-gaap_CommonStockValue 111us-gaap_CommonStockValue
Additional paid-in capital 324,053us-gaap_AdditionalPaidInCapitalCommonStock 235,351us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated other comprehensive income 1,222us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 4,628us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated deficit (219,296)us-gaap_RetainedEarningsAccumulatedDeficit (208,202)us-gaap_RetainedEarningsAccumulatedDeficit
Total shareholders' equity 106,116us-gaap_StockholdersEquity 31,888us-gaap_StockholdersEquity
Total liabilities and shareholders' equity $ 114,986us-gaap_LiabilitiesAndStockholdersEquity $ 56,711us-gaap_LiabilitiesAndStockholdersEquity